"In their search for markets abroad the company have engaged Austrade post operations, to tap links with appropriate medical and dental distribution networks. The company has set-up a North American headquarter outside Dallas, Texas a European headquarter in Zurich, Switzerland and is expanding into Asia through its Asia Pacific headquarter in Sydney. SomnoMed® is a third-time Export Market Development Grant (EMDG) recipient. The grants have assisted the company with meeting the costs of overseas marketing visits, appointing overseas representatives and marketing consultants, advertising, distributing free samples of their products and attending trade fairs." (http://www.austrade.gov.au/Default.aspx?PrintFriendly=True&ArticleID=3723)
and Somnomed still making use of that funding in Europe in 2009 - http://www.expoorto.com/expositores.php
SOM Price at posting:
46.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)